TRT: The Complete UK Guide to Testosterone Replacement Therapy

Testosterone replacement therapy (TRT) is the most effective intervention for hypogonadism. It's also widely misunderstood, sometimes inaccessible on the NHS, and frequently misused outside clinical contexts.

This is the complete guide: diagnosis, protocols, monitoring, benefits, risks, and long-term management.

What TRT Actually Is

TRT is pharmaceutical testosterone administration to restore testosterone to physiologic (normal) levels in men with documented deficiency.

It's not:

• Performance enhancement for normal men
• An anti-aging supplement
• A shortcut to muscle growth for healthy individuals

It is:

• A legitimate medical treatment for hypogonadism
• Effective for restoring sexual function, energy, and body composition in deficient men
• Safe when properly monitored
• Increasingly accessible in the UK (both NHS and private)

Signs and Symptoms of Low Testosterone

Hypogonadism presents with a constellation of symptoms. No single symptom is diagnostic, but clusters are meaningful.

Sexual symptoms:

• Reduced libido (desire for sex)
• Erectile dysfunction or reduced erectile quality
• Reduced ejaculate volume
• Reduced sexual satisfaction

Energy and mood:

• Fatigue (particularly morning fatigue)
• Reduced motivation and drive
• Depression or anhedonia (inability to feel pleasure)
• Reduced sense of wellbeing
• Brain fog or difficulty concentrating

Physical changes:

• Loss of muscle mass
• Increased body fat (particularly visceral fat)
• Reduced strength or performance
• Reduced bone density (sometimes detected as fractures)
• Reduced body hair

Sleep:

• Reduced sleep quality
• Increased sleep disruption
• Sleep apnea (testosterone deficiency is associated with sleep disorders)

Other:

• Hot flushes or night sweats (counterintuitive but real—can indicate severe deficiency)
• Breast tissue development (gynaecomastia) if additional hormonal imbalances exist

Important: These symptoms overlap with depression, sleep disorders, metabolic dysfunction, and thyroid disease. Symptoms alone aren't diagnostic. You need biochemical confirmation.

Diagnosis: How Low Is "Low"?

Diagnosis requires both symptoms and bloodwork.

Biochemical criteria: UK guideline bodies (BSSM 2022, NICE) recommend TRT for men with:

• Symptoms consistent with hypogonadism AND
• Serum testosterone < 8 nmol/L (230 ng/dL) on at least two morning tests

Some guidelines use < 10 nmol/L (290 ng/dL) as a threshold depending on symptom severity.

Normal ranges (for reference):

• 10-30 nmol/L (290-870 ng/dL) — normal adult male range
• 8-10 nmol/L (230-290 ng/dL) — low-normal (may warrant TRT if symptomatic)
• < 8 nmol/L (< 230 ng/dL) — hypogonadism (TRT typically indicated if symptomatic)

Why two tests? Testosterone varies day-to-day, even hour-to-hour. Two tests (preferably morning tests, when testosterone is highest) ensure you're not diagnosed on an anomalously low reading.

When to test:

• 8-10 AM (testosterone peaks in early morning)
• After adequate sleep
• After 3 days of minimal stress and exercise (stress acutely lowers testosterone)
• On a fasted blood draw (food affects some assays)

Types of Hypogonadism

Understanding the cause matters for treatment decisions.

Primary hypogonadism (testicular dysfunction):

• The testes aren't producing adequate testosterone
• Causes: genetic (Klinefelter syndrome), injury, infection, cancer treatment, undescended testes
• Labs: high testosterone is low, LH and FSH are elevated (testes compensate by signalling harder)
• TRT is straightforward; fertility recovery is difficult

Secondary hypogonadism (pituitary/hypothalamic dysfunction):

• The brain isn't signalling the testes to produce testosterone
• Causes: head injury, pituitary tumour, obesity, opioid use, anabolic steroid suppression
• Labs: testosterone is low, LH and FSH are low or low-normal
• TRT works but may suppress natural production further; alternatives (hCG, enclomiphene) may preserve fertility

Mixed: Some men have elements of both.

Diagnosis distinguishes these:

• If total testosterone is low, measure LH and FSH
• High LH/FSH with low testosterone = primary
• Low/low-normal LH/FSH with low testosterone = secondary
• If secondary hypogonadism: consider pituitary imaging (MRI) to rule out tumours

This matters because it affects treatment decisions (TRT vs. fertility-preserving approaches) and what investigations are needed.

NHS TRT Access (2026 Update)

NHS testosterone replacement is improving. Recent updates (NICE guidance 2024, BSSM 2022) have streamlined access.

NHS pathway:

1. GP appointment: Present with symptoms, request testosterone testing
2. Blood tests: Two fasting morning testosterone tests, plus LH/FSH
3. GP assessment: If criteria met, GP can either initiate TRT or refer to endocrinology
4. Many GPs now initiate TRT directly without endocrinology referral
5. If referred to endocrinology: Waiting time varies regionally (6-16 weeks)
6. Treatment initiation: Usually testosterone gel first-line
7. Follow-up: 6-8 weeks after starting, then 3-6 months, then annually once stable

Current NHS advantages:

• Free treatment (after GP visit cost)
• Proper diagnostic workup (pituitary assessment if secondary hypogonadism)
• GP oversight and integration with primary care
• Safe monitoring protocol

Current NHS limitations:

• Longer waiting times (8-16 weeks for endocrinology)
• Gel is default (some men prefer injections)
• Less flexibility on protocols
• Limited access to ancillary medications (aromatase inhibitors, hCG)

2026 reality: NHS now handles straightforward cases directly. Waiting is shorter than 2 years ago. If you have symptoms + low testosterone + no complications, NHS is viable.

Private TRT Clinics (Quick Access)

Private clinics offer 2-4 week turnaround, more flexible protocols, and access to injectable testosterone and ancillary medications.

Cost: £150-300 initial consultation, £40-100 monthly.

Main UK private TRT clinics: Optimale, Balance My Hormones, Fountain TRT, Leger Clinic.

See dedicated article "Best TRT Clinics UK 2026" for detailed comparison.

Private vs. NHS decision:

• If you can wait 12+ weeks: NHS is excellent and free
• If you need TRT in 2-4 weeks: private is necessary
• If you want injectable testosterone as first-line: private is easier
• If you want aromatase inhibitor or hCG access: private is more flexible

Testosterone Delivery Methods

Several options exist. None is objectively "best"; the best choice depends on individual factors.

Testosterone Gel (Transdermal)

Forms: Testogel, Testim, Androgel

Dose: 50-100mg daily (varies by product and individual absorption)

How: Apply to clean, dry skin (shoulders, abdomen, or inner thighs—avoid genitals)

Pros:

• Non-invasive
• Avoid first-pass hepatic metabolism
• Flexible dosing
• Physiologic testosterone levels
• No injection anxiety

Cons:

• Absorption variable (affected by skin condition, temperature, hydration)
• Cost higher than injections (approximately £40-60/month private)
• Requires daily application
• Skin irritation possible
• Transfer to partners (wash hands, cover application site)
• Transference to children if not careful (genuine risk)

Typical timeline to stability: 4-6 weeks

Testosterone Enanthate or Cypionate (Intramuscular Injection)

Dose: 50-100mg weekly (typical), or 100-200mg every two weeks

How: IM injection into glute, thigh, or shoulder (rotate sites)

Frequency: Weekly or every 10-14 days (depending on dosing preference)

Pros:

• Cost-effective (£10-20/month for compounded testosterone)
• Precise dosing
• No absorption variability
• Stable testosterone levels
• Can be self-injected at home
• Most commonly used by experienced TRT users

Cons:

• Injection anxiety (though most men adapt quickly)
• Requires subcutaneous injections
• Testosterone levels fluctuate slightly (higher immediately post-injection, decline toward end of interval)
• Requires medical training/comfort with injections

Typical timeline to stability: 3-4 weeks

Injection technique:

1. Use 25G or 27G needle (smaller gauge = less tissue trauma)
2. 1mL per injection (0.5mL enanthate = 50mg, varies by concentration)
3. IM injection (into muscle, not subcutaneous)
4. Rotate injection sites to avoid lipohypertrophy
5. Dispose of needles appropriately

Where to inject:

• Glutes: largest muscle, most forgiving
• Vastus lateralis (outer thigh): acceptable, easier to self-inject
• Deltoid: smaller muscle, acceptable for smaller volumes
• Rotate sites weekly

Testosterone Undecanoate (Restandol, Oral)

Dose: 120-160mg daily in divided doses with food

How: Oral capsule with fatty meals

Pros:

• Oral (no injections)
• Avoids first-pass hepatic metabolism due to lymphatic absorption
• Physiologic dosing possible

Cons:

• Requires multiple daily doses
• Must take with food (absorption is food-dependent)
• Less common in UK (not first-line)
• Absorption is variable
• More expensive than injections

Use case: Men with needle anxiety who tolerate injections, or those who want oral dosing for convenience (though frequency makes it less convenient than it sounds).

Testosterone Pellets

Dose: 600-1200mg implanted pellet, lasts 3-6 months

How: Subcutaneous pellet inserted under skin (requires minor procedure)

Pros:

• Long-acting (3-6 months between applications)
• Physiologic levels
• No daily application or frequent injections

Cons:

• Requires medical procedure for insertion and removal
• Expensive (£200-400 per pellet every 3-6 months)
• Less common in UK
• Removal difficult if side effects develop (pellet dissolution takes weeks)
• Absorption rate not easily adjustable post-insertion

Current status: Not widely available on NHS; available at some private clinics.

Subcutaneous Injection

Testosterone can be injected subcutaneously (under skin) rather than intramuscular. Smaller needles (27G-29G), smaller volumes possible.

Pros:

• Less injection anxiety (smaller needle, shallower injection)
• Easier to self-inject
• Equal effectiveness

Cons:

• Less established in UK (requires compounded testosterone at lower concentrations)
• Lipohypertrophy risk if same site used repeatedly

Increasingly popular among experienced TRT users; ask private clinics if they offer this.

Starting Dose and Titration

There's no universal starting dose. Individual factors matter:

Typical starting doses:

• Testosterone gel: 50-100mg daily
• Testosterone enanthate/cypionate: 50-100mg weekly
• Testosterone undecanoate: 120-160mg daily (divided)

Factors affecting starting dose:

• Current testosterone level (lower baseline may require higher initial dose)
• Body weight (heavier men sometimes need slightly higher doses)
• Individual metabolism (varies)
• Symptoms (severity sometimes guides dose)

Titration protocol:

1. Start at lower-to-moderate dose
2. Test at 4-6 weeks
3. Adjust dose based on testosterone level AND symptom response
4. Retest 4-6 weeks after adjustment
5. Once stable, test less frequently (every 6-12 months)

Target testosterone range:

• Total testosterone: 10-30 nmol/L (290-870 ng/dL)—normal male range
• Most men feel best at 15-25 nmol/L (430-720 ng/dL)
• Below 15 nmol/L or above 30 nmol/L requires adjustment

Avoid overshooting: Some men push doses too high chasing maximum benefits. This causes:

• Elevated oestradiol (water retention, mood changes)
• Elevated haematocrit (polycythaemia—blood thickening)
• Acne and skin issues
• Mood irritability
• Elevated PSA (in susceptible men)

Start low, titrate carefully, find your dose range.

Monitoring on TRT

Proper monitoring is essential for safety and efficacy.

Initial phase (first 3-6 months):

• Bloodwork at 4-6 weeks (assess testosterone level, make dose adjustments)
• Bloodwork at 8-12 weeks (confirm stability)
• Clinical assessment (symptoms, side effects, adherence)

Ongoing (after stability):

• Bloodwork annually at minimum
• More frequent if on aromatase inhibitors or if making dose changes

What to monitor:

Essential:

• Total testosterone (to confirm dose is adequate)
• Haematocrit (polycythaemia is main dose-dependent risk)
• PSA (prostate-specific antigen; baseline and ongoing)
• Blood pressure

Important:

• Oestradiol (if elevated, may need aromatase inhibitor or dose reduction)
• Lipids (testosterone can affect lipid profile slightly)
• Liver function (generally fine on TRT, but baseline is sensible)

Consider:

• Bone density (DEXA) if long-term hypogonadism was present—testosterone improves bone
• Sleep apnea screening (if symptoms present—TRT can exacerbate sleep apnea)

Practical monitoring schedule:

• Week 4-6: testosterone, haematocrit, PSA
• Week 12: repeat testosterone, haematocrit
• Every 6-12 months thereafter: testosterone, haematocrit, PSA, lipids, BP

Most private clinics handle this; NHS does as well.

Expected Timeline of Benefits

TRT works, but benefits accrue on different timescales.

Fast (2-4 weeks):

• Increased energy and motivation
• Improved mood and sense of wellbeing
• Improved erections and libido (often surprisingly quick)
• Better sleep quality

Medium (6-12 weeks):

• Significant muscle gain (with training)
• Fat loss (modest, 2-5kg over 3 months typical)
• Strength improvements
• Improved body composition

Slower (3-6 months):

• Substantial lean mass gain (5-10kg muscle gain over 6 months typical with training)
• Significant fat loss (5-10kg over 6 months typical)
• Bone density improvements (begin, but take 6-12 months to be significant)
• Skin quality and body hair changes

Very slow (6-12 months):

• Bone density fully normalized
• Cardiovascular improvements (if baseline risk was present)
• Cognitive improvements (subtle)

Not reversible quickly: If you stop TRT, benefits regress over weeks-to-months (libido and mood fastest; muscle loss takes longer).

Potential Side Effects and Risks

TRT is safe, but not risk-free. Honest discussion of real risks is important.

Haematocrit Elevation (Polycythaemia)

What: Excessive red blood cell production, thickening blood.

Mechanism: Testosterone stimulates erythropoietin (EPO) production, increasing RBC count.

Incidence: 20-30% of men on TRT experience some elevation; clinically significant polycythaemia (haematocrit >54%) in 5-10%.

Symptoms: Generally asymptomatic until severe; severe polycythaemia causes headaches, visual symptoms, clotting risk.

Monitoring: Haematocrit every 4-6 weeks initially, then every 6-12 months.

Management:

• Donate blood (phlebotomy) if haematocrit >54%
• Reduce TRT dose if persistent elevation
• Adequate hydration (helps)
• Most men stabilize at haematocrit 48-52% on stable dose

Risk factors: Age >50, higher TRT dose, pre-existing elevated baseline haematocrit.

PSA Elevation and Prostate Cancer

What: TRT can increase PSA (prostate-specific antigen), a marker for prostate issues.

Important context: Elevated PSA doesn't mean prostate cancer. Many benign conditions elevate PSA (BPH, prostatitis). Prostate cancer is common in older men regardless of TRT.

Mechanism: Testosterone supports prostate tissue. Higher testosterone can increase PSA.

Evidence:

• TRT doesn't cause prostate cancer (large observational studies show no increased cancer risk)
• TRT may accelerate existing prostate cancer (theoretical risk, not clearly demonstrated in practice)
• PSA typically rises by 0.5-1 ng/mL in first year on TRT, then plateaus

Monitoring:

• PSA at baseline (before starting TRT)
• PSA at 6-12 months (to establish new baseline on TRT)
• PSA annually thereafter
• If PSA rises >1.4 ng/mL in a year, or absolute value >4 ng/mL, urology referral

Risk factors for prostate issues: Age >50, family history of prostate cancer, baseline elevated PSA.

Management:

• Most men tolerate modest PSA elevation (1-3 ng/mL) fine on TRT
• Some require dose reduction if PSA rises excessively
• Dutasteride (5-alpha reductase inhibitor) reduces DHT-driven PSA elevation; some men use it on TRT to blunt PSA rise

Acne and Skin Changes

Incidence: 5-10% experience acne or worsening of pre-existing acne.

Mechanism: Testosterone increases sebum production and androgenic skin effects.

Management: Reduce dose if possible, improve skin hygiene, isotretinoin if severe (requires dermatology).

Gynecomastia (Breast Tissue Development)

Incidence: Uncommon on well-managed TRT; 2-5%.

Cause: Excessive aromatisation to oestradiol, or individual sensitivity.

Management:

• Reduce TRT dose first
• If dose is appropriate and gynecomastia develops, aromatase inhibitor may help
• Severe cases may require surgery

Mood and Behavioral Changes

Potential: Some men report mood changes (irritability, aggression, anger).

Incidence: Unclear from data; anecdotal reports suggest 5-15%.

Context: Excessive doses more likely to cause mood changes; physiologic doses less so.

Mechanism: Unclear; possible effects on neurotransmitters (dopamine, serotonin).

Management: Reduce dose if behavioral changes develop.

Fertility Suppression

What: TRT suppresses natural testosterone production, reducing sperm production and testicular volume.

Mechanism: Exogenous testosterone suppresses LH and FSH, reducing testicular signalling.

Incidence: ~100% (all men on TRT experience some suppression).

Reversibility: Usually reversible; after stopping TRT, fertility typically returns over 3-12 months. Longer TRT use means longer recovery.

If fertility is important:

• Discuss before starting TRT
• Consider alternatives: enclomiphene (preserves fertility by stimulating endogenous production), or hCG therapy alongside TRT
• If you want children, plan accordingly

Lipid Changes

What: TRT can modestly affect lipid profile (cholesterol, triglycerides, HDL).

Direction: Variable; some men see favorable changes, others less favorable.

Monitoring: Lipid panel annually.

Risk: Minimal if lipids remain in healthy range; if substantially worsened, consider dose reduction or stopping.

Sleep Apnea

Association: TRT can worsen pre-existing sleep apnea or unmask mild sleep apnea.

Mechanism: Testosterone affects upper airway muscle tone and breathing control.

Risk: Higher in men who are obese or have baseline sleep apnea risk.

Screening: Ask about sleep symptoms (snoring, daytime somnolence, witnessed apneas) before starting; consider sleep study if risk present.

Stopping TRT: Reversibility and Permanence

Can you stop TRT?

Yes. TRT is reversible.

What happens:

• Natural testosterone production restarts within weeks (if was previously working)
• Testosterone level drops back to baseline (low) over 3-4 weeks
• Benefits fade: energy/mood within 1-2 weeks, libido within 2-4 weeks, muscle over months
• Fertility returns over 3-12 months (longer if longer TRT duration)

Is it permanent once you start?

Not biologically. But practically, if you had hypogonadism before TRT, you likely still have it after stopping. You'd need to decide whether to go back on TRT or accept the symptoms.

Long-term commitment:

TRT is typically lifelong if you have primary hypogonadism (testicular failure). If secondary hypogonadism (from obesity, opioid use, etc.), addressing the underlying cause may allow TRT discontinuation.

Special Populations

Young Men (18-30) with Hypogonadism

Rare but real. Some young men have primary or secondary hypogonadism.

Key difference: Fertility concerns are paramount.

Approach: If secondary (pituitary/hypothalamic), address underlying cause first (weight loss, stopping opioids, etc.). If that doesn't restore testosterone, consider enclomiphene or hCG therapy before TRT to preserve fertility.

If primary (testicular failure), TRT is indicated; fertility is poor regardless.

Older Men (70+)

TRT is safe in older men. Age alone is not a contraindication.

Considerations: Higher baseline cardiovascular risk; closer monitoring advisable.

Benefit: Sexual function, energy, and muscle mass improvements are especially valuable in older age.

Men with Pre-Existing Cardiovascular Disease

TRT is not contraindicated. Many men with CVD benefit from TRT.

Monitoring: More frequent blood pressure and lipid monitoring; closer clinical oversight.

Risk: Very high dose TRT in men with severe CVD requires caution; physiologic doses are generally safe.

Summary: The Complete TRT Picture

TRT is:

• Effective for restoring testosterone in hypogonadal men
• Safe when properly monitored
• Accessible on NHS (with waiting times) or private (with cost)
• Reversible (though may be lifelong if hypogonadism is permanent)
• Appropriate for men with documented deficiency and symptoms

Before starting TRT:

1. Confirm hypogonadism with bloodwork (two morning tests)
2. Assess for underlying cause (primary vs. secondary)
3. Understand your options (TRT vs. alternatives like enclomiphene)
4. Plan monitoring schedule
5. Discuss fertility implications if relevant
6. Choose delivery method aligned with your preferences

On TRT:

1. Start conservatively
2. Titrate based on bloodwork and symptoms
3. Monitor regularly (haematocrit, PSA, testosterone, lipids)
4. Expect benefits on different timescales
5. Manage side effects proactively

Long-term:

1. Recheck bloodwork annually
2. Maintain communication with your prescriber
3. Understand this is typically long-term or permanent
4. Reassess dosing periodically; avoid dose creep

TRT is one of the most evidence-based interventions in medicine for men with documented hypogonadism. When used appropriately—diagnosis confirmed, monitoring in place, dose optimized—it's safe, effective, and transformative.

The UK healthcare system (NHS and private) now supports straightforward access. There's no reason to suffer hypogonadism untreated.